Aktie A2DG46 MEDIXALL GROUP, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen MediXall Group, Inc. Other OTC

Aktien

A2DG46

US58504K1043

MDXL

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
MediXall Group, Inc. Announces CFO Changes
MediXall Group, Inc. Appoints Scott S. Powell as Member of Its Board of Directors
MediXall Group, Inc. Appoints Robert L. Hood as Member of the Board of Directors
Medixall Group Inc. Announces Partnership with Oxio Health, Inc. to Offer Access to Centralized Personal Health Record Using Artificial Intelligence
MediXall Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Medixall Group, Inc. Announces Resignation Michael J. Swartz as President, Secretary and Board Member
MEDIXALL GROUP, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
MEDIXALL GROUP, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Medixall Group, Inc. Announces CFO Changes
MEDIXALL GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
MediXall Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
MEDIXALL GROUP, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
MediXall Group, Inc. Announces Board Changes
MediXall Group, Inc. Appoints Richard Paull, Chief Financial Officer
MEDIXALL GROUP, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
MediXall Group, Inc. Announces Executive Changes
MediXall Group, Inc. Announces Board Changes
MEDIXALL GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
MediXall Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
MEDIXALL GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DG46 Aktie
  4. A2DG46 Aktie
  5. Nachrichten MediXall Group, Inc.
  6. Andere Sprachen